Cargando…

Correction: Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system

Detalles Bibliográficos
Autores principales:	Das, Krishna, Eisel, David, Lenkl, Clarissa, Goyal, Ashish, Diederichs, Sven, Dickes, Elke, Osen, Wolfram, Eichmüller, Stefan B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6300243/ https://www.ncbi.nlm.nih.gov/pubmed/30566524 http://dx.doi.org/10.1371/journal.pone.0209719

Ejemplares similares

Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system
por: Das, Krishna, et al.
Publicado: (2017)

Cognate Interaction With CD4(+) T Cells Instructs Tumor-Associated Macrophages to Acquire M1-Like Phenotype
por: Eisel, David, et al.
Publicado: (2019)

Radiation-induced alterations in immunogenicity of a murine pancreatic ductal adenocarcinoma cell line
por: Schröter, Philipp, et al.
Publicado: (2020)

MicroRNAs affecting the susceptibility of melanoma cells to CD8(+) T cell‐mediated cytolysis
por: Pane, Antonino A., et al.
Publicado: (2023)

Challenges of CRISPR/Cas9 applications for long non-coding RNA genes
por: Goyal, Ashish, et al.
Publicado: (2017)

miR-193b and miR-30c-1(*) inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro
por: Kordaß, Theresa, et al.
Publicado: (2018)

Reprogramming of macrophages employing gene regulatory and metabolic network models
por: Hörhold, Franziska, et al.
Publicado: (2020)

A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice
por: Das, Krishna, et al.
Publicado: (2019)

MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion
por: Ast, Volker, et al.
Publicado: (2018)

Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E
por: Kordaß, Theresa, et al.
Publicado: (2018)

SOX9 is a target of miR-134-3p and miR-224-3p in breast cancer cell lines
por: Chao, Tsu-Yang, et al.
Publicado: (2022)

Novel microRNAs modulating ecto-5′-nucleotidase expression
por: Kordaß, Theresa, et al.
Publicado: (2023)

Reprogramming MHC specificity by CRISPR-Cas9-assisted cassette exchange
por: Kelton, William, et al.
Publicado: (2017)

Photon versus carbon ion irradiation: immunomodulatory effects exerted on murine tumor cell lines
por: Hartmann, Laura, et al.
Publicado: (2020)

AAV-Mediated CRISPR/Cas9 Gene Editing in Murine Phenylketonuria
por: Richards, Daelyn Y., et al.
Publicado: (2019)

Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy
por: Lei, Janet, et al.
Publicado: (2015)

Imbalanced MHC class II molecule expression at surface of murine B cell lymphomas
Publicado: (1986)

Structural and dynamic views of the CRISPR-Cas system at the single-molecule level
por: Lee, Seung Hwan, et al.
Publicado: (2016)

Prediction and validation of murine MHC class I epitopes of the recombinant virus VSV-GP
por: Vijver, Saskia V., et al.
Publicado: (2023)

CRISPR/Cas9-mediated knock-in of the murine Y chromosomal Sry gene
por: IMAIMATSU, Kenya, et al.
Publicado: (2018)

Generation of gene-of-interest knockouts in murine organoids using CRISPR-Cas9
por: Huber, Anne, et al.
Publicado: (2023)

Rapid generation of novel models of RAG1 deficiency by CRISPR/Cas9-induced mutagenesis in murine zygotes
por: de Bruin, Lisa Ott, et al.
Publicado: (2016)

CRISPR-Cas9 Mediated Labelling Allows for Single Molecule Imaging and Resolution
por: Khan, Abdullah O., et al.
Publicado: (2017)

Identification and Analysis of Small Molecule Inhibitors of CRISPR-Cas9 in Human Cells
por: Yang, Yue, et al.
Publicado: (2022)

Potent Antitumor Activity of Liposomal Irinotecan in an Organoid- and CRISPR-Cas9-Based Murine Model of Gallbladder Cancer
por: Erlangga, Zulrahman, et al.
Publicado: (2019)

An optimized electroporation approach for efficient CRISPR/Cas9 genome editing in murine zygotes
por: Tröder, Simon E., et al.
Publicado: (2018)

Reverse Signaling by MHC-I Molecules in Immune and Non-Immune Cell Types
por: Muntjewerff, Elke M., et al.
Publicado: (2020)

Machine learning in the estimation of CRISPR-Cas9 cleavage sites for plant system
por: Das, Jutan, et al.
Publicado: (2023)

Superantigen and class II MHC molecules.
por: Kim, J.
Publicado: (1995)

Elimination of infectious HIV DNA by CRISPR–Cas9
por: Das, Atze T, et al.
Publicado: (2019)

MetaMHC: a meta approach to predict peptides binding to MHC molecules
por: Hu, Xihao, et al.
Publicado: (2010)

Improving transgene expression and CRISPR‐Cas9 efficiency with molecular engineering‐based molecules
por: Zhan, Hengji, et al.
Publicado: (2020)

CRISPR/Cas9-based coronal nanostructures for targeted mitochondria single molecule imaging
por: Zhao, Xuan, et al.
Publicado: (2022)

Aptamer-based CRISPR-Cas powered diagnostics of diverse biomarkers and small molecule targets
por: Kadam, Ulhas Sopanrao, et al.
Publicado: (2023)

Highly Efficient Gene Disruption of Murine and Human Hematopoietic Progenitor Cells by CRISPR/Cas9
por: Brunetti, Lorenzo, et al.
Publicado: (2018)

Start codon disruption with CRISPR/Cas9 prevents murine Fuchs’ endothelial corneal dystrophy
por: Uehara, Hironori, et al.
Publicado: (2021)

Screening of Human Tumor Antigens for CD4(+) T Cell Epitopes by Combination of HLA-Transgenic Mice, Recombinant Adenovirus and Antigen Peptide Libraries
por: Osen, Wolfram, et al.
Publicado: (2010)

Cas6 specificity and CRISPR RNA loading in a complex CRISPR-Cas system
por: Sokolowski, Richard D., et al.
Publicado: (2014)

Immunotoxin Against a Donor MHC Class II Molecule Induces Indefinite Survival of Murine Kidney Allografts
por: Brown, K., et al.
Publicado: (2016)

Safeguarding CRISPR-Cas9 gene drives in yeast
por: DiCarlo, James E., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0hrgesb7906d1fuev8soei1tak